CAS 20175-84-2: Isodiospyrin

Isodiospyrin is a novel human DNA topoisomerase I inhibitor, it exhibits cytotoxic activity to tumor cell lines. Isodiospyrin has antibacterial activity, the minimum inhibitory concentrations (MICs) against Gram-positive bacteria ranged from 0.78 to 50 mi

Isodiospyrin is a natural compound identified as a naphthoquinone derivative, which is typically derived from bacterial sources, particularly from actinomycetes. Its mode of action involves the disruption of bacterial cell processes, often targeting specific enzymes critical for cell wall synthesis or DNA replication, making it effective against certain bacterial strains. Isodiospyrin exhibits promising antibacterial properties, which have been explored in the context of combating resistant microbial infections. Its application in microbiology and pharmacology research is significant, as it provides insights into novel antimicrobial mechanisms. By studying its effects, scientists aim to develop new therapeutic agents that can address antibiotic resistance, a growing concern in medical treatment. Detailed investigations continue to unravel its potential and broaden its applicability in designing drugs for infectious disease management.